Stock VTI VISIONEERING TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Visioneering Technologies, Inc.

Equities

VTI

AU000000VTI2

Market Closed - Australian S.E.
Other stock markets
 11:22:47 02/05/2024 am IST 		5-day change 1st Jan Change
0.096 AUD -4.00% Intraday chart for Visioneering Technologies, Inc. -45.14% -61.60%
24/04 Transcript : Visioneering Technologies, Inc., Q1 2024 Earnings Call, Apr 23, 2024
28/02 Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Visioneering Technologies Issues Part of Shortfall from Rights Offering
VTI gibt positive vorläufige 1-Jahres-Daten aus der klinischen PROTECT-Studie auf der Jahrestagung der American Academy of Optometry bekannt
Visioneering Technologies Raising Funds for Clinical Trial, Business Expansion
Visioneering Technologies, Inc. Announces the Appointment of Juan Carlos Aragón as Chief Executive Officer, Effective 1 October 2023
Visioneering Technologies, Inc. Announces the Appointment of Juan Carlos Aragón as Executive Director, Effective 1 October 2023
Visioneering Technologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Visioneering Technologies, Inc. Announces Board Changes
Visioneering Technologies, Inc. Enrolls 100% of Subjects in its International Randomized Controlled Clinical Trial Known as PROTECT
Visioneering Technologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Visioneering Technologies Reaches 50% Enrolment Milestone in Nearsightedness Clinical Trial
Visioneering Technologies, Inc. Achieves 50% Enrollment Milestone in its PROTECT International Clinical Study for Myopia Progression Control
Visioneering Technologies, Inc. Announces Board Changes
Visioneering Technologies, Inc. Provides Revenue Guidance for the Year 2022
Visioneering Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Visioneering Technologies Enrolls First Patient for Contact Lens Clinical Trial; Shares Rise 3%
Visioneering Technologies, Inc. Announces Initiation of the Protect Clinical Trial
Visioneering Technologies' CEO Resigns
Visioneering Technologies Says Multifocal Contact Lenses Prevents Myopia Progression
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VTI Stock
  4. News Visioneering Technologies, Inc.
  5. Other languages